Roche CEO Severin Schwan is preparing the Swiss drug giant for a battle it hasn't faced before: competition from generic copies of its cancer-fighting biotech drugs.
WSJ.com: What's News US, Wall Street Journal
Sun, 10/31/2010 - 5:30pm
Roche CEO Severin Schwan is preparing the Swiss drug giant for a battle it hasn't faced before: competition from generic copies of its cancer-fighting biotech drugs.